Literature DB >> 7724998

Activated CD4+ and CD8+ T-cell subsets in Wegener's granulomatosis.

M Schlesier1, T Kaspar, J Gutfleisch, G Wolff-Vorbeck, H H Peter.   

Abstract

Several lines of evidence argue in favour of an involvement of T cells in the pathogenesis of Wegener's granulomatosis (WG). These include the presence of highly specific IgG autoantibodies to proteinase 3, perivascular T-cell infiltrates and elevated amounts of soluble interleukin-2 (IL-2) receptors in patient's serum. In order to further address this question we evaluated by double immunofluorescence and flow cytometry the expression of several cell surface molecules associated with T-cell activation. As compared to healthy controls (n = 15), the CD4+ subset was significantly diminished, while the percentage of CD8+ T cells was elevated in WG patients (n = 24). Within the CD4+ T-cell subset we found a highly significant increase in activation/memory markers (CD25, CD29, HLA-DR). Within the CD8+ T-cell subset the expression of CD11b, CD29 and CD57 was significantly elevated, while the expression of VD28 was reduced. The use of 10 V beta-, 1 V alpha- and 1 V gamma-specific monoclonal reagents failed to reveal any significant bias in the peripheral T-cell receptor V-gene repertoire of WG patients. There was also no correlation between T-cell activation markers and laboratory parameters [C-reactive protein (CRP), ESR], disease duration or therapy. A significant correlation was found only for the degree of organ involvement and the increase in CD4+ T cells coexpressing HLA-DR, as well as the increase in CD57 expression on CD8+ T cells. In conclusion, both CD4+ and CD8+ T-cell subsets were activated in WG. Cytotoxic CD8+CD57+CD11b+CD28- T cells may directly contribute to damage of vascular endothelium.

Entities:  

Mesh:

Year:  1995        PMID: 7724998     DOI: 10.1007/bf00262300

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  37 in total

1.  Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen.

Authors:  J H Phillips; L L Lanier
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

2.  Increased Leu-7-positive T lymphocytes during cytomegalovirus infection following allogeneic bone marrow transplantation for hematologic malignancies.

Authors:  S J Forman; J A Zaia; C Wright; M T Gallagher; K G Blume
Journal:  Transplantation       Date:  1986-02       Impact factor: 4.939

3.  Persistence of T8+/HNK-1+ suppressor lymphocytes in the blood of long-term surviving patients after allogeneic bone marrow transplantation.

Authors:  E Leroy; C F Calvo; M Divine; M F Gourdin; F Baujean; M H Ben Aribia; Z Mishal; J P Vernant; J P Farcet; A Senik
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

4.  Autoantibodies against cytoplasmic structures of neutrophil granulocytes in Wegener's granulomatosis.

Authors:  G Lüdemann; W L Gross
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

Review 5.  Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences.

Authors:  E C Hagen; B E Ballieux; L A van Es; M R Daha; F J van der Woude
Journal:  Blood       Date:  1993-04-15       Impact factor: 22.113

6.  Lymphokine production by T-cell clones after human bone marrow transplantation.

Authors:  A Velardi; P Varese; A Terenzi; C Dembech; N Albi; C E Grossi; L Moretta; M F Martelli; F Grignani; M C Mingari
Journal:  Blood       Date:  1989-10       Impact factor: 22.113

7.  Membrane surface proteinase 3 expression and intracytoplasmic immunoglobulin on neutrophils from patients with ANCA-associated vasculitides.

Authors:  E Csernok; W H Schmitt; M Ernst; D F Bainton; W L Gross
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

8.  Increased percentage of CD3+, CD57+ lymphocytes in patients with rheumatoid arthritis. Correlation with duration of disease.

Authors:  A Dupuy d'Angeac; S Monier; C Jorgensen; Q Gao; A Travaglio-Encinoza; C Bologna; B Combe; J Sany; T Rème
Journal:  Arthritis Rheum       Date:  1993-05

9.  Functional abnormalities of CD8+ T cells define a unique subset of patients with common variable immunodeficiency.

Authors:  J S Jaffe; W Strober; M C Sneller
Journal:  Blood       Date:  1993-07-01       Impact factor: 22.113

10.  CD11b (Mac-1): a marker for CD8+ cytotoxic T cell activation and memory in virus infection.

Authors:  H I McFarland; S R Nahill; J W Maciaszek; R M Welsh
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

View more
  24 in total

Review 1.  Cellular aspects of vasculitis--T cell-mediated aspects.

Authors:  M E Griffith; C D Pusey
Journal:  Springer Semin Immunopathol       Date:  2001

2.  Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis.

Authors:  Andras Komocsi; Peter Lamprecht; Elena Csernok; Antje Mueller; Konstanze Holl-Ulrich; Ulrike Seitzer; Frank Moosig; Armin Schnabel; Wolfgang Ludwig Gross
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 3.  Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.

Authors:  P Lamprecht
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

Review 4.  Pulmonary vasculitis: classification, clinical features, and management.

Authors:  A Ciaccia; M Ferrari; F M Facchini; G Caramori; L Fabbri
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

Review 5.  Could Lymphocyte Profiling be Useful to Diagnose Systemic Autoimmune Diseases?

Authors:  Guillermo Carvajal Alegria; Pierre Gazeau; Sophie Hillion; Claire I Daïen; Divi Y K Cornec
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

6.  Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis.

Authors:  S Marinaki; I Neumann; A-I Kälsch; P Grimminger; A Breedijk; R Birck; W Schmitt; R Waldherr; B A Yard; F J Van Der Woude
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

7.  Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells.

Authors:  Matthew D Morgan; Clara J Day; Karen P Piper; Naeem Khan; Lorraine Harper; Paul A Moss; Caroline O S Savage
Journal:  Immunology       Date:  2010-01-27       Impact factor: 7.397

8.  An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's).

Authors:  Carol A Langford; Paul A Monach; Ulrich Specks; Philip Seo; David Cuthbertson; Carol A McAlear; Steven R Ytterberg; Gary S Hoffman; Jeffrey P Krischer; Peter A Merkel
Journal:  Ann Rheum Dis       Date:  2013-12-09       Impact factor: 19.103

9.  Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis.

Authors:  E R Popa; C A Stegeman; N A Bos; C G M Kallenberg; J W Cohen Tervaert
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

10.  CD45RC isoform expression identifies functionally distinct T cell subsets differentially distributed between healthy individuals and AAV patients.

Authors:  Laurence Ordonez; Isabelle Bernard; Fatima-Ezzahra L'faqihi-Olive; Jan Willem Cohen Tervaert; Jan Damoiseaux; Abdelhadi Saoudi
Journal:  PLoS One       Date:  2009-04-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.